Weight Loss, GLP-1 Injections, Branded Medications

Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply — Complete Product Information & Specifications

FDA-approved Zepbound® (tirzepatide) dual GIP and GLP-1 receptor agonist once-weekly autoinjector pen delivering up to 20.9%–22.5% average clinical weight loss.

Product overview

Zepbound® (tirzepatide) is the first FDA-approved dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist indicated for chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity. In the SURMOUNT-1 clinical trial, non-diabetic adults receiving the 15 mg maintenance dose achieved an unprecedented 20.9% to 22.5% average reduction in total body weight over 72 weeks.

By synergistically activating both incretin pathways (GIP and GLP-1), Zepbound provides superior appetite regulation, improved adipose tissue lipid metabolism, and enhanced insulin sensitivity compared to single-agonist therapies. Patients initiate therapy at 2.5 mg once weekly for 4 weeks before escalating in 2.5 mg increments every 4 weeks as clinically tolerated.

Through Join Amble Health, patients complete a streamlined online medical intake reviewed by a licensed healthcare provider. When clinically appropriate, your prescription or wellness protocol is fulfilled by a vetted partner pharmacy and shipped directly to your door with clear administration instructions, dosing schedules, and ongoing clinical support.

Product specifications

Product Name	Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply
SKU	AMB-ZEPBOUND-PEN
Category	Weight Loss, GLP-1 Injections, Branded Medications
Active Ingredients & Strength	Tirzepatide (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL single-dose pen)
Dosage Form & Schedule	FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) — Inject once weekly subcutaneously in the abdomen, thigh, or upper arm
Price	$1,059.00
Availability	In stock (Provider Evaluation Required)

Product features

Genuine Eli Lilly FDA-approved dual GIP/GLP-1 autoinjector pens (4 single-dose pens per monthly box).
Highest clinically demonstrated weight reduction among approved incretin mimetics (up to 22.5% in SURMOUNT-1).
Comprehensive provider titration management from 2.5 mg starter dose through 15 mg maintenance.
Structured specification table and transparent monthly program pricing with no hidden membership fees.
Direct pharmacy fulfillment with lot traceability, patient administration guides, and provider messaging access.

Quality and documentation

Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply is an FDA-approved prescription brand medication dispensed in original manufacturer-sealed single-dose or multi-dose autoinjector pens through licensed U.S. partner pharmacies after a complete medical evaluation by a licensed healthcare provider.

Every order is accompanied by pharmacy-issued labeling detailing the active ingredient concentrations, beyond-use date (BUD) or manufacturer expiration date, lot number, and step-by-step patient administration instructions. Patients should verify the package seal and storage instructions immediately upon delivery.

Storage and handling

Refrigerate between 36°F to 46°F (2°C to 8°C). Single pen may be stored unrefrigerated up to 86°F (30°C) for up to 21 days.

Always keep medications and bioactive peptides out of reach of children and pets. Do not use any product past the printed expiration or beyond-use date on the pharmacy label, and never share prescription medications with another person.

Important product information

Product descriptions on Join Amble Health are provided for educational and catalog transparency purposes and do not replace individualized medical advice, diagnosis, or treatment from a licensed clinician. Eligibility for prescription weight management, hormone optimization, peptide therapy, or dermatological treatment is determined solely by your evaluating healthcare provider based on your medical history, current medications, contraindications, and laboratory findings where required.

Price, delivery and purchase terms

Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply is listed at $1,059.00 in the Amble Health Shop under Weight Loss, GLP-1 Injections, Branded Medications. Temperature-sensitive injectable and biological formulations are shipped via expedited insulated cold-chain carrier, while room-temperature oral, sublingual, nasal, and topical formulations ship in discreet protective packaging with full tracking.

Frequently asked questions

What is included with Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply?

Each 4-week supply of Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply (AMB-ZEPBOUND-PEN) includes the prescribed formulation (Tirzepatide (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL single-dose pen) in FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) format), complete pharmacy labeling, administration supplies if applicable, and ongoing asynchronous clinical support through your Amble patient portal.

How is Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply administered?

Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply is formulated as a FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) and is typically used according to the following schedule: Inject once weekly subcutaneously in the abdomen, thigh, or upper arm. Your prescribing clinician will provide personalized dosing and titration instructions tailored to your clinical goals and tolerance.

Do I need a prescription or medical consultation for Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply?

Yes. After selecting your treatment plan, you will complete a comprehensive online health intake. A licensed healthcare provider in your state reviews your medical history, contraindications, and treatment goals before issuing a prescription to our partner pharmacy.

How should I store Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply once it arrives?

Refrigerate between 36°F to 46°F (2°C to 8°C). Single pen may be stored unrefrigerated up to 86°F (30°C) for up to 21 days. Always inspect the pharmacy label upon arrival and follow the specific storage temperature and light-protection guidelines printed on your container.

Can Zepbound® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply be combined with other Amble Health protocols?

Many patients pair metabolic, longevity, or dermatological protocols under clinician supervision—such as combining GLP-1 therapy with NAD+ cellular support or gastro-protective B6/B12 co-factors. Disclose all current medications and supplements during intake so your provider can verify compatibility.

Where can I review pricing and shipping updates?

Current pricing ($1,059.00), stock status, and delivery terms are displayed directly on this product page and in your checkout summary prior to order confirmation.

Product and regulatory references

US online ordering information

Information for customers reviewing Zepbound Tirzepatide Pen online from the United States.

A catalog listing or an enabled Add to cart button is not clinical approval or confirmation of lawful dispensing. Before ordering, confirm the exact formulation, strength, quantity, required prescription review, dispensing pharmacy and eligibility in your state. No nationwide prescribing or fulfillment coverage is implied.

Use the live price and stock display on this page and review the final checkout total. Delivery, tax and return conditions depend on the product and destination; do not assume a delivery date or eligibility from this page alone.

For product or ordering questions, email hello@joinamblehealth.com. Read the Amble terms of service or visit your Amble account.